Genmab Overview
Genmab Target Price
Analysts' 12-month price predictions for GMAB.
Share Price
$21.81
Average Target Price
$45.00
106.3% upside
106.3% upside1 analysts in the last 4 months
High: $45 | Low: $45
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-11 | Truist FinancialAsthika Goonewardene | $45 | 106.3% upside |  |
| 2024-09-04 | Morgan StanleyVikram Purohit | $31 | 42.1% upside | |
| 2024-08-09 | BMO CapitalEtzer Darout | $46 | 110.9% upside | |
| 2024-06-27 | BTIGKaveri Pohlman | $47 | 115.5% upside | |
| 2024-06-27 | H.C. WainwrightRaghuram Selvaraju | $50 | 129.3% upside | |
| 2024-06-04 | Truist FinancialAsthika Goonewardene | $53 | 143% upside | |
| 2024-02-23 | BMO CapitalEtzer Darout | $48 | 120.1% upside | |
| 2023-02-06 | Leerink Partners | $36 | 65.1% upside | |
| 2022-11-28 | Morgan StanleyMatthew Harrison | $34 | 55.9% upside | |
| 2022-05-02 | Cowen & Co. | $38 | 74.2% upside | |